The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Thoughts?

Forums Cutaneous Melanoma Community Thoughts?

  • Post
    pasadenagirl
    Participant

      Has anyone ever heard of this test?   Thoughts?  I'm currently 1b dx june 2014, although I try hard to put it out of my mind and know that my chances of never dealing with melanoma again are excellent.  It' lurks in the back of my mind, what if??   

       

      http://skinmelanoma.com/know-your-risk/know-your-metastic-risk/

       

      Know Your Metastatic Risk

      An accurate prognosis can have significant impact on post-operative care

       

      About 60,000 people are diagnosed each year with early stage, non-metastatic melanoma. Some of them will go on to develop aggressive metastatic disease. In fact, according to the American Cancer Society, 3% of Stage IA, and 9% of IB tumors will turn deadly within 5 years. In addition, 19% of Stage IIA, 30% of IIB, and 47% of IIC melanomas will likely prove fatal over a 5-year period.

      The DecisionDx-Melanoma™ test is designed to identify the Stage I and II patients whose tumor biology suggests they are at higher or lower risk of metastasis than their stage might indicate. The test uses sophisticated technology to measure the “expression” or activity of specific genes known to play a role in metastasis, and classifies tumors as either Class 1, with a 3% chance of spreading within 5 years, or Class 2, with a 69% risk of metastasis.

      Gene testing is an advance made possible by breakthroughs in genomic, or personalized, medicine. While staging categories (I-IV) are based on the outcomes of large groups of patients whose cancer shared similar characteristics (tumor thickness, mitotic rate, ulceration, presence in the lymph nodes, etc.), gene testing analyzes an individual’s own tumor tissue to estimate their metastatic risk. This “individualized” information, in combination with staging, can help doctors and early stage patients better determine how aggressively to monitor, and in some cases, treat their disease.

      It’s important to talk to you doctor to decide if the gene test is right for you. To guide the discussion, download the “Talk to Your Doctor” guide.

    Viewing 5 reply threads
    • Replies
        Janner
        Participant

          The test runs about $9000.  I'm not sure insurance covers it.  My institution thinks it has merit but is still trying to determine which people would be best served by having the test done because of the cost.

          Janner
          Participant

            The test runs about $9000.  I'm not sure insurance covers it.  My institution thinks it has merit but is still trying to determine which people would be best served by having the test done because of the cost.

            Janner
            Participant

              The test runs about $9000.  I'm not sure insurance covers it.  My institution thinks it has merit but is still trying to determine which people would be best served by having the test done because of the cost.

              JC
              Participant

                I was going to try to have this done but when my slide was reviewed it was determined that given their requirements for analysis more tumor tissue was needed (the focus of my IA tumor was small)

                JC
                Participant

                  I was going to try to have this done but when my slide was reviewed it was determined that given their requirements for analysis more tumor tissue was needed (the focus of my IA tumor was small)

                  JC
                  Participant

                    I was going to try to have this done but when my slide was reviewed it was determined that given their requirements for analysis more tumor tissue was needed (the focus of my IA tumor was small)

                Viewing 5 reply threads
                • You must be logged in to reply to this topic.
                About the MRF Patient Forum

                The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.